Veronique Lecault, Chief Operating Officer at AbCellera Biologics Inc. (ABCL), bought 461,578 shares at $8.66 ($4.0M) on 2022-02-28, disclosed to the SEC on 2022-03-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.66 | 230,789 | $2.0M | 50.0% |
| 2 | $8.66 | 230,789 | $2.0M | 50.0% |
| Total | $8.66 avg | 461,578 | $4.0M | 100% |
| Filing → |
| ABCL | SELL | 2021-06-10 | $25.5M | — | Filing → |
| ABCL | BUY | 2020-12-17 | $460K | — | Filing → |